77
Views
4
CrossRef citations to date
0
Altmetric
Interaction Between γ-Rays, Cisplatin and Etoposide

Lethal and mutagenic interactions between γ-rays, cisplatin and etoposide at the cellular and molecular levels

, &
Pages 222-230 | Received 18 Mar 2010, Accepted 19 Aug 2010, Published online: 06 Dec 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Anthony J Berdis. (2014) Current and emerging strategies to increase the efficacy of ionizing radiation in the treatment of cancer. Expert Opinion on Drug Discovery 9:2, pages 167-181.
Read now

Articles from other publishers (3)

N. Bracesco, V. Sosa, L. Blanc, V. Contreras, E.C. Candreva, V.A. Salvo, S. Hocart, B. Mechoso & E. Nunes. (2018) Analysis of radioprotection and antimutagenic effects of Ilex paraguariensis infusion and its component rutin. Brazilian Journal of Medical and Biological Research 51:9.
Crossref
Mariana Gonda, Marcos Nieves, Elia Nunes, Adela López de Ceráin, Antonio Monge, María Laura Lavaggi, Mercedes González & Hugo Cerecetto. (2013) Phenazine N,N′-dioxide scaffold as selective hypoxic cytotoxin pharmacophore. Structural modifications looking for further DNA topoisomerase II-inhibition activity. MedChemComm 4:3, pages 595.
Crossref
Renata Matuo, Fabrício G. Sousa, Daniele G. Soares, Diego Bonatto, Jenifer Saffi, Alexandre E. Escargueil, Annette K. Larsen & João Antonio Pêgas Henriques. (2012) Saccharomyces cerevisiae as a model system to study the response to anticancer agents. Cancer Chemotherapy and Pharmacology 70:4, pages 491-502.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.